首页 | 本学科首页   官方微博 | 高级检索  
检索        


SC‐1, a sorafenib derivative,shows anti‐tumor effects in osteogenic sarcoma cells
Authors:Chen‐Ti Wang  Chen‐Si Lin  Chung‐Wai Shiau  Pei‐Yi Chu  Chung‐Ching Hsiao  Yi‐Lun Chiang  Wei‐Tien Tai  Kuen‐Feng Chen
Institution:1. Department of Orthopedics, National Taiwan University Hospital, Taipei, Taiwan;2. School of Veterinary Medicine, National Taiwan University, Taipei, Taiwan;3. Institute of Biopharmaceutical Sciences, National Yang‐Ming University, Taipei, Taiwan;4. Department of Pathology, St. Martin De Porres Hospital, Chiayi, Taiwan;5. Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan;6. National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan
Abstract:
Keywords:SC‐1  sorafenib  STAT3  osteogenic sarcoma
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号